02 9541 3500How to Develop RNA Vaccines from Concept to Clinic
17 Jan, 2022 | Newsletters
| Recorded sessions now available for viewing: Vaccines from Concept to Clinic Explore the experiences and insights from the front lines of RNA vaccine research. Particularly, stories highlighting the challenges and solutions faced when developing RNA vaccines from the earliest stages through to the clinic. WATCH ALL SESSIONS HERE The Vaccine Evolution View the Recording  Accelerate the Preclinical Development of RNA Vaccines View the Recording  Ehrlichia mRNA Vaccines: Overcoming the Vaccine Development Roadblock View the recording  RNA Manufacturing: Considerations to Accelerate the Path to Clinic View the Recording  Scale Up and Manufacturing of Self-Amplifying RNA-LNPs for a COVID-19 vaccine View the recording  Flexible Approaches to Addressing mRNA Vaccine Demand View the Recording  |
| CALL US FOR A PERSONAL DEMONSTRATION Bookings are available now. Should you wish to use this instrument or need further information regarding training or help to create lipid, polymer or hybrid nanoparticle formulations carrying small molecules, peptides nucleic acids (and more), please contact Peter Davis, pdavis@atascientific.com.au, or call Peter directly on his mobile 0417 778 971.  Take a closer look: Book your NanoAssemblr Ignite demo Rapid, reproducible and scalable manufacture of nanoparticle formulations Finely tune particle size with precise control over fluid flow rates using laminar flow conditions Create highly reproducible mRNA LNPs with high mRNA encapsulation efficacy and potency within seconds. Simplify and accelerate nanomedicine formulation using one single mixing element — from formulation to full GMP Precision NanoSystems’ Genetic Vaccine Toolkit provides essential technologies to facilitate development of mRNA vaccines – Click here. |
| Contact us for a demo Request a quote now Email us for more info |